About Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Clinical Trials at Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
During the past decade, Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
According to Clinical.Site data, the most researched conditions in "Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie" are
"Breast Cancer" (3 trials), "Breast Neoplasms" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie" in a lesser frequency.
Clinical Trials Intervention Types at Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Most popular intervention types in "Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
The vast majority of trials in "Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Currently, there are NaN active trials in "Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".